SCHEMBL6582489

SCHEMBL6582489

CCCC(Cc1ccccc1COc1cccc(OCc2ccc3ccccc3n2)c1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 13/20 0.61
CYSLTR2 Q9NS75 10/20 0.61
GPBAR1 Q8TDU6 7/20 0.58
MAPK1 P28482 2/20 0.55
TP53 P04637 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
CYP2C19 P33261 1/20 0.55
HIF1A Q16665 1/20 0.55
MEN1 O00255 1/20 0.55
GMNN O75496 1/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
ALOX5 P09917 1/20 0.55
HPGD P15428 1/20 0.55
PTGS1 P23219 1/20 0.55
PTGS2 P35354 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581010 0.93 CYSLTR2 (0.62) CYSLTR1CYSLTR2GPBAR1ALOX5
SCHEMBL6584606 0.87 CYSLTR1 (0.51) CYSLTR1CYSLTR2GPBAR1MAPK1TP53
SCHEMBL6091295 0.87 CYSLTR1 (0.65) CYSLTR1CYSLTR2GPBAR1
SCHEMBL6092416 0.83 CYSLTR1 (0.58) CYSLTR1CYSLTR2GPBAR1MAPK1TP53
SCHEMBL14021575 0.83 CYSLTR1 (0.65) CYSLTR1CYSLTR2GPBAR1MAPK1TP53
SCHEMBL10544491 0.82 CYSLTR1 (0.66) CYSLTR1CYSLTR2GPBAR1
SCHEMBL6090813 0.80 CYSLTR1 (0.69) CYSLTR1CYSLTR2GPBAR1ALOX5
SCHEMBL6091833 0.80 CYSLTR1 (0.54) CYSLTR1CYSLTR2GPBAR1MAPK1TP53
SCHEMBL5725146 0.79 CYSLTR1 (0.67) CYSLTR1CYSLTR2GPBAR1
SCHEMBL6090484 0.79 CYSLTR1 (0.73) CYSLTR1CYSLTR2GPBAR1MAPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784052-B1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation AVENTIS HOLDINGS INC (US) 2004-09-01 EP disclosed
EP-0784052-A1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1997-07-16 EP disclosed
WO-1989012628-A1 QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-12-28 WO disclosed
EP-0348155-A1 Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-12-27 EP disclosed